Clinical trial No longer in our active list Interventional Ages 16 to 100

Using gel sheets to treat burn scars

Official title: Randomized, Controlled, Within-patient Study to Evaluate the Efficacy of a Nonsilicone Gel Sheet for the Treatment of Hypertrophic Scar in Adult Burn Survivors

Run by Centre hospitalier de l'Université de Montréal (CHUM) · NCT05429411 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether a special gel sheet can help prevent and improve scars from deep burns in people who have experienced these injuries.

Quick facts

Study typeInterventional
Ages16 Years to 100 Years
SexAll
Enrollment36 (estimated)
SponsorCentre hospitalier de l'Université de Montréal (CHUM)
Academic / other
Locations1 site (Montréal)
Trial IDNCT05429411 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 16 and older who have been admitted for thermal burn treatment and exhibit clinical signs of hypertrophic scars.

Probably not a fit

Patients with mature scars, keloid scars, or those with specific dermatological conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a non-silicone gel sheet in preventing and treating hypertrophic scars resulting from deep dermal burn injuries. Participants will wear the gel sheets for increasing durations, starting from 4 hours and gradually progressing to over 21 hours daily. The study employs a randomized, controlled, within-patient design, comparing the treatment site with a patient-matched control site to ensure accurate assessment of outcomes. The use of validated electronic measurement tools aims to provide objective data on scar improvement.

Why it matters

Potential benefit: If successful, this treatment could significantly improve the management of hypertrophic scars, enhancing patient quality of life.

How similar studies have gone: Previous studies on gel sheets for scar treatment have shown mixed results, indicating a need for more rigorous evaluation like this one.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Females and males, of any race
* 16 years or older who were admitted to the Montreal Burn Centre for the treatment of a thermal burn injury
* Scar sites that show clinical evidence of HSc (\>2.034 mm thick as measured by high frequency ultrasound and hyperaemic - defined as Mexameter erythema index \>300)
* Understand French or English
* Signed the informed patient consent form.

Exclusion Criteria:

* Suspected or known allergy to ultrasound gel
* Formed keloid scars
* Scar site that are mature (defined as Mexameter erythema index \<300 and \<2.034 mm thick)
* Diagnosed with a psychiatric illness that will impair the subjects ability to participate in the study or provide informed consent
* Mechanism of injury is an electrical, chemical, or cold injury
* Dermatological condition such as psoriasis, eczema, etc., in the region of the evaluation site, which in the investigator's opinion, may interfere with the study results.

Where it's running

  • Villa Medica Rehabilitation Hospital
    Montréal, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.